Insider Buying: Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Purchases 1,500 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHIGet Free Report) President Amir F. Heshmatpour acquired 1,500 shares of Neonc Technologies stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average price of $7.30 per share, for a total transaction of $10,950.00. Following the transaction, the president now owns 1,756,490 shares of the company’s stock, valued at $12,822,377. This represents a 0.09% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Neonc Technologies Trading Down 1.0%

Shares of Neonc Technologies stock opened at $7.18 on Thursday. Neonc Technologies Holdings, Inc. has a one year low of $4.11 and a one year high of $25.00. The stock’s 50 day moving average is $7.78.

Neonc Technologies (NASDAQ:NTHIGet Free Report) last announced its quarterly earnings data on Friday, May 9th. The company reported ($2.10) EPS for the quarter. The company had revenue of $0.04 million during the quarter.

Hedge Funds Weigh In On Neonc Technologies

A hedge fund recently bought a new stake in Neonc Technologies stock. Royal Bank of Canada bought a new stake in Neonc Technologies Holdings, Inc. (NASDAQ:NTHIFree Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 18,525 shares of the company’s stock, valued at approximately $247,000.

About Neonc Technologies

(Get Free Report)

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.

Recommended Stories

Insider Buying and Selling by Quarter for Neonc Technologies (NASDAQ:NTHI)

Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.